Femyso: Affected Lot May Contain Two Green Mifepristone Cartons Or Two Pink Misoprostol Cartons Instead Of One Of Each.

Recalling firm: Lupin Pharma Canada Limited.
Product: Femyso Mifepristone 200mg / Misoprostol 200 mcg tablet
Reason: Packaging defect
Classification: Class II
Category: drug recall
Country: Canada
Agency: HC-DRUGS
Recall date: 2026-10-21
Status: Ongoing
Distribution: Canada-wide

Recall details on Nibble Recalls: https://trynibble.app/recalls/dd7b9e67-d687-4e17-bbff-6ca232028314